First Foundation Advisors Merck & Co., Inc. Transaction History

First Foundation Advisors

$2.58 Billion
Q3 2024

A detailed history of First Foundation Advisors transactions in Merck & Co., Inc. stock. As of the latest transaction made, First Foundation Advisors holds 13,544 shares of MRK stock, worth $1.3 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

13,544

Previous 14,775 8.33%

Holding current value

$1.3 Million

Previous $1.83 Million 15.91%

% of portfolio

0.06%

Previous 0.07%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$111.15 - $128.97 $136,825 - $158,762	-1,231 Reduced 8.33%	13,544 $1.54 Million
Q2 2024 Aug 06, 2024	SELL	$123.8 - $132.96 $87,279 - $93,736	-705 Reduced 4.55%	14,775 $1.83 Million
Q1 2024 May 09, 2024	BUY	$113.24 - $131.95 $70,661 - $82,336	624 Added 4.2%	15,480 $2.04 Million
Q4 2023 Feb 14, 2024	SELL	$100.18 - $109.02 $593,165 - $645,507	-5,921 Reduced 28.5%	14,856 $1.62 Million
Q3 2023 Nov 15, 2023	SELL	$102.95 - $114.33 $69,182 - $76,829	-672 Reduced 3.13%	20,777 $2.14 Million
Q2 2023 Aug 14, 2023	BUY	$108.61 - $118.38 $5,430 - $5,919	50 Added 0.23%	21,449 $2.48 Million
Q1 2023 May 12, 2023	SELL	$102.94 - $114.86 $1.64 Million - $1.84 Million	-15,979 Reduced 42.75%	21,399 $2.28 Million
Q4 2022 Feb 14, 2023	BUY	$87.44 - $112.11 $53,863 - $69,059	616 Added 1.68%	37,378 $4.15 Million
Q3 2022 Nov 10, 2022	BUY	$84.53 - $94.96 $462,210 - $519,241	5,468 Added 17.47%	36,762 $3.17 Million
Q2 2022 Aug 12, 2022	SELL	$83.49 - $94.64 $918 - $1,041	-11 Reduced 0.04%	31,294 $2.85 Million
Q1 2022 May 05, 2022	BUY	$73.51 - $82.4 $425,549 - $477,013	5,789 Added 22.69%	31,305 $2.57 Million
Q4 2021 Feb 14, 2022	BUY	$72.28 - $90.54 $195,951 - $245,453	2,711 Added 11.89%	25,516 $1.96 Million
Q3 2021 Nov 15, 2021	BUY	$71.68 - $78.83 $105,512 - $116,037	1,472 Added 6.9%	22,805 $1.71 Million
Q2 2021 Aug 13, 2021	SELL	$70.31 - $77.77 $663,445 - $733,837	-9,436 Reduced 30.67%	21,333 $1.66 Million
Q1 2021 May 18, 2021	BUY	$68.86 - $81.11 $884,437 - $1.04 Million	12,844 Added 71.65%	30,769 $2.37 Million
Q4 2020 Feb 16, 2021	BUY	$71.77 - $79.65 $38,396 - $42,612	535 Added 3.08%	17,925 $1.47 Million
Q3 2020 Nov 12, 2020	BUY	$73.18 - $82.95 $65,203 - $73,908	891 Added 5.4%	17,390 $1.44 Million
Q2 2020 Aug 14, 2020	SELL	$70.42 - $80.13 $62,532 - $71,155	-888 Reduced 5.11%	16,499 $1.28 Million
Q1 2020 May 11, 2020	BUY	$63.36 - $87.82 $133,752 - $185,388	2,111 Added 13.82%	17,387 $1.34 Million
Q4 2019 Feb 11, 2020	SELL	$77.58 - $87.54 $9,387 - $10,592	-121 Reduced 0.79%	15,276 $1.39 Million
Q3 2019 Nov 12, 2019	SELL	$76.08 - $82.93 $81,786 - $89,149	-1,075 Reduced 6.53%	15,397 $1.3 Million
Q2 2019 Aug 14, 2019	BUY	$69.84 - $81.59 $97,077 - $113,410	1,390 Added 9.22%	16,472 $1.38 Million
Q1 2019 May 13, 2019	SELL	$69.58 - $79.36 $27,971 - $31,902	-402 Reduced 2.6%	15,082 $1.25 Million
Q4 2018 Feb 14, 2019	SELL	$65.24 - $75.71 $38,556 - $44,744	-591 Reduced 3.68%	15,484 $1.18 Million
Q3 2018 Nov 13, 2018	SELL	$57.69 - $67.84 $30,748 - $36,158	-533 Reduced 3.21%	16,075 $1.14 Million
Q2 2018 Aug 14, 2018	BUY	$50.83 - $59.72 $101,405 - $119,141	1,995 Added 13.65%	16,608 $1.01 Million
Q1 2018 May 15, 2018	SELL	$50.96 - $59.23 $195,737 - $227,502	-3,841 Reduced 20.81%	14,613 $796,000
Q4 2017 Feb 14, 2018	SELL	$51.62 - $61.64 $197,136 - $235,403	-3,819 Reduced 17.15%	18,454 $1.04 Million
Q3 2017 Nov 14, 2017	SELL	$58.67 - $63.13 $281,322 - $302,708	-4,795 Reduced 17.71%	22,273 $1.43 Million
Q2 2017 Aug 14, 2017	BUY	N/A	27,068	27,068 $1.74 Million

Others Institutions Holding MRK

# of Institutions

3,821

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $244B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Foundation Advisors, based on Form 13F filings with the SEC.

News

Stay updated on First Foundation Advisors with notifications on news.

Account

First Foundation Advisors Merck & Co., Inc. Transaction History